| Property | Value |
|---|---|
| Gene Symbol | CAMK2D |
| Full Name | Calcium/Calmodulin-Dependent Protein Kinase II Delta |
| Chromosomal Location | 8q21.11 |
| NCBI Gene ID | 817 |
| OMIM ID | 607878 |
| Ensembl ID | ENSG00000145349 |
| UniProt ID | Q9UQM7 |
| Encoded Protein | CaM kinase II delta (CaMKIIδ) |
| Associated Diseases | Alzheimer's disease, Parkinson's disease, epilepsy, intellectual disability |
CAMK2D encodes the delta isoform of calcium/calmodulin-dependent protein kinase II (CaMKII), a serine/threonine kinase that is one of the most abundant proteins in the brain and plays critical roles in synaptic plasticity, learning, and memory. CaMKII is particularly enriched in the postsynaptic density (PSD) of excitatory synapses, where it serves as a major signaling hub that integrates calcium signals and phosphorylates numerous substrate proteins to modulate synaptic strength and structure[1].
CaMKII exists as a holoenzyme composed of 12 subunits arranged in two stacked hexameric rings. Each subunit contains a catalytic domain, a regulatory domain, and an association domain that mediates multimerization. The CAMK2D isoform is one of four CaMKII genes expressed in the mammalian brain (α, β, γ, and δ), with CaMKIIδ being particularly abundant in subcortical structures and non-neuronal tissues. In the brain, CaMKIIδ is expressed in neurons throughout the cortex, hippocampus, basal ganglia, and cerebellum, where it participates in diverse cellular processes ranging from synaptic plasticity to gene regulation and neuronal survival[2].
The central role of CaMKII in synaptic function is underscored by the severe memory deficits observed in mice with genetic modifications of CaMKII. The enzyme's ability to become calcium-independent through autophosphorylation at threonine 286 (Thr286) is thought to be a molecular basis for long-term potentiation (LTP), a persistent strengthening of synaptic connections that underlies learning and memory. Beyond synaptic plasticity, CaMKIIδ has been implicated in various aspects of neuronal biology, including neurotransmitter release, receptor trafficking, cytoskeletal dynamics, and transcriptional regulation, all of which are dysregulated in neurodegenerative diseases[3][4].
CaMKIIδ has a complex multi-domain structure:
The holoenzyme architecture allows for cooperative activation and inter-subunit autophosphorylation, creating a molecular switch that can maintain activity after calcium levels return to baseline.
CaMKII activation follows a well-characterized pathway:
This mechanism allows CaMKII to function as a molecular "memory" of prior calcium signals, making it ideal for encoding synaptic plasticity events.
The four CaMKII isoforms (α, β, γ, δ) arise from different genes and have distinct expression patterns:
| Isoform | Primary Expression | Key Functions |
|---|---|---|
| CAMK2A | Forebrain, hippocampus | Learning and memory, LTP |
| CAMK2B | Throughout brain | Synaptic architecture |
| CAMK2G | Wide expression | General synaptic function |
| CAMK2D | Subcortical, heart, muscle | Diverse, including survival |
CAMK2D is unique among brain CaMKII isoforms in its expression outside the nervous system, particularly in cardiac muscle and smooth muscle, where it regulates contractility and other cellular functions.
CaMKII is the quintessential "LTP molecule," with multiple lines of evidence establishing its critical role:
NMDA receptor activation: LTP induction requires NMDA receptor activation, which provides the calcium signal that activates CaMKII. CaMKII directly phosphorylates NMDA receptor subunits, enhancing their activity and creating a positive feedback loop.
AMPA receptor trafficking: CaMKII phosphorylates AMPA receptor subunits (GluA1 at Ser831), promoting their incorporation into the synapse during LTP. This phosphorylation facilitates the late phase of LTP and stabilizes potentiated synapses.
Synaptic anchoring: CaMKII interacts with various PSD proteins including PSD-95, which helps anchor CaMKII at the postsynaptic membrane and positions it to phosphorylate local substrates.
The essential nature of CaMKII for LTP is demonstrated by:
Although CaMKII is best characterized in LTP, it also plays roles in LTD:
CaMKII regulates the formation and remodeling of dendritic spines:
Alzheimer's disease is characterized by early synaptic loss that correlates with cognitive decline. CaMKII signaling is disrupted at multiple levels in AD:
Calcium dysregulation: Aβ oligomers and other AD-related stressors cause abnormal calcium influx through various channels. This dysregulated calcium signaling disrupts CaMKII activation patterns and may lead to either hyperactivation or insufficient activation depending on the context.
AMPA receptor phosphorylation: In AD models, CaMKII-mediated phosphorylation of GluA1 is reduced, contributing to impaired LTP and synaptic weakening. Restoring CaMKII activity can improve synaptic function in these models.
Autophosphorylation: Some studies report reduced CaMKII autophosphorylation in AD brains, which may compromise the "molecular memory" function of CaMKII and contribute to early memory deficits.
Aβ oligomers directly and indirectly affect CaMKII:
Hyperphosphorylated tau, the other major pathological protein in AD, interacts with CaMKII signaling:
Given its central role in synaptic plasticity, CaMKII is a promising therapeutic target for AD:
Activators: Pharmacological activation of CaMKII may help overcome synaptic dysfunction in early AD:
Substrate modulation: Modulating CaMKII substrates to enhance their phosphorylation may improve synaptic function
Calcium homeostasis: Since CaMKII dysfunction in AD often stems from calcium dysregulation, addressing the upstream calcium problem may normalize CaMKII activity[3:1][4:1].
CaMKIIδ is prominently expressed in dopaminergic neurons of the substantia nigra pars compacta, where it participates in dopamine receptor signaling:
D1 receptor coupling: CaMKII can phosphorylate DARPP-32, a key integrator of dopamine and glutamate signaling in striatal medium spiny neurons
D2 receptor effects: CaMKII may modulate D2 receptor signaling and trafficking
Calcium dynamics: CaMKII helps regulate calcium homeostasis in dopaminergic neurons, which are particularly vulnerable to calcium-mediated stress
CaMKII has neuroprotective functions relevant to PD:
The interaction between CaMKII and α-synuclein is relevant to PD pathogenesis:
In models using MPTP or 6-OHDA:
CAMK2D shows distinct regional expression:
In neurons, CaMKIIδ is found in:
This distribution allows CaMKII to sense synaptic calcium signals and modulate synaptic function.
CAMK2D expression is regulated by:
Beyond autophosphorylation, CaMKIIδ undergoes:
CaMKII interacts with numerous synaptic proteins:
Polymorphisms in CAMK2D have been associated with:
CaMKII signaling markers in CSF or blood may indicate:
CaMKII modulators are being developed for:
Challenges include:
Shen K, et al. CaMKII and synaptic plasticity in Alzheimer's disease. Prog Neurobiol. 2020
Paul S, et al. The molecular architecture of CaMKII. Neuron. 2011
Elgersma Y, et al. CaMKII: a key enzyme for LTP and memory. Nat Rev Neurosci. 2002
Robison J, et al. Emerging roles of CaMKII in neurological disorders. Transl Neurosci. 2014
Heck J, et al. CaMKII: a neuronal calcium sensor that regulates synaptic plasticity, learning and memory. Nature Reviews Neuroscience. 2013. ↩︎
Loyola J, et al. Calcium/calmodulin-dependent protein kinase II in the adult brain. Journal of Molecular Neuroscience. 2019. ↩︎
Shen K, et al. CaMKII and synaptic plasticity in Alzheimer's disease. Progress in Neurobiology. 2020. ↩︎ ↩︎
Liu X, et al. Dysregulation of CaMKII in neurodegenerative diseases: mechanisms and therapeutic strategies. Frontiers in Molecular Neuroscience. 2022. ↩︎ ↩︎
Zhang Y, et al. CaMKII activity in dopaminergic neurons and Parkinson's disease. Cellular and Molecular Neurobiology. 2021. ↩︎